Privia Health Group, Inc. Interest Expense
Privia Health Group, Inc. (PRVA) reported Interest Expense of $500.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2023-03-01
- Privia Health Group, Inc. interest expense for the quarter ending 2022-03-31 was $200.00K, a 33.33% decline year-over-year.
- Privia Health Group, Inc. interest expense for the quarter ending 2021-12-31 was $200.00K, a 50.00% decline year-over-year.
- Privia Health Group, Inc. interest expense for the quarter ending 2021-09-30 was $300.00K, a 40.00% decline year-over-year.
- Privia Health Group, Inc. interest expense for the quarter ending 2021-06-30 was $300.00K, a 40.00% decline year-over-year.
- Privia Health Group, Inc. interest expense for fiscal 2022 was $500.00K, a 54.55% decline from fiscal 2021.
- Privia Health Group, Inc. interest expense for fiscal 2021 was $1.10M, a 42.11% decline from fiscal 2020.
- Privia Health Group, Inc. interest expense for fiscal 2020 was $1.90M, a 52.50% decline from fiscal 2019.
- Privia Health Group, Inc. interest expense for fiscal 2019 was $4.00M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $500.00K 10-K · filed 2023-03-01 | |||
| 2022-03-31 | $200.00K 10-Q · filed 2022-05-12 | $400.00K derived: sum of 2 quarters · filed 2023-03-01 | $700.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.00M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $500.00K derived: sum of 2 quarters · filed 2023-03-01 | $800.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.10M 10-K · filed 2023-03-01 |
| 2021-09-30 | $300.00K 10-Q · filed 2021-11-08 | $600.00K derived: sum of 2 quarters · filed 2021-11-08 | $900.00K 10-Q · filed 2021-11-08 | $1.30M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $300.00K 10-Q · filed 2021-08-09 | $600.00K 10-Q · filed 2021-08-09 | $1.00M derived: sum of 3 quarters · filed 2023-03-01 | $1.50M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-12 | $700.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.20M derived: sum of 3 quarters · filed 2023-03-01 | $1.70M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $900.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.40M derived: sum of 3 quarters · filed 2023-03-01 | $1.90M 10-K · filed 2023-03-01 |
| 2020-09-30 | $500.00K 10-Q · filed 2021-11-08 | $1.00M derived: sum of 2 quarters · filed 2021-11-08 | $1.50M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $500.00K 10-Q · filed 2021-08-09 | $1.00M 10-Q · filed 2021-08-09 | ||
| 2019-12-31 | $4.00M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |